Literature DB >> 14742545

Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis.

Hai Qi1, Jiaxiang Ji, Nanchaya Wanasen, Lynn Soong.   

Abstract

During Leishmania major infection in mice, gamma interferon (IFN-gamma) plays an essential role in controlling parasite growth and disease progression. In studies designed to ascertain the role of IFN-gamma in Leishmania amazonensis infection, we were surprised to find that IFN-gamma could promote L. amazonensis amastigote replication in macrophages (Mphis), although it activated Mphis to kill promastigotes. The replication-promoting effect of IFN-gamma on amastigotes was independent of the source and genetic background of Mphis, was apparently not affected by surface opsonization of amastigotes, was not mediated by interleukin-10 or transforming growth factor beta, and was observed at different temperatures. Consistent with the different fates of promastigotes and amastigotes in IFN-gamma-stimulated Mphis, L. amazonensis-specific Th1 transfer helped recipient mice control L. amazonensis infection established by promastigotes but not L. amazonensis infection established by amastigotes. On the other hand, IFN-gamma could stimulate Mphis to limit amastigote replication when it was coupled with lipopolysaccharides but not when it was coupled with tumor necrosis factor alpha. Thus, IFN-gamma may play a bidirectional role at the level of parasite-Mphi interactions; when it is optimally coupled with other factors, it has a protective effect against infection, and in the absence of such synergy it promotes amastigote growth. These results reveal a quite unexpected aspect of the L. amazonensis parasite and have important implications for understanding the pathogenesis of the disease and for developing vaccines and immunotherapies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14742545      PMCID: PMC321581          DOI: 10.1128/IAI.72.2.988-995.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation.

Authors:  I Vouldoukis; P A Bécherel; V Riveros-Moreno; M Arock; O da Silva; P Debré; D Mazier; M D Mossalayi
Journal:  Eur J Immunol       Date:  1997-04       Impact factor: 5.532

Review 2.  Regulation of cationic amino acid transporter (CAT) gene expression.

Authors:  C L MacLeod
Journal:  Biochem Soc Trans       Date:  1996-08       Impact factor: 5.407

3.  Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection.

Authors:  L Soong; C H Chang; J Sun; B J Longley; N H Ruddle; R A Flavell; D McMahon-Pratt
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

4.  Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8+ T cells do not mediate a protective immune response.

Authors:  K Erb; C Blank; U Ritter; H Bluethmann; H Moll
Journal:  Immunobiology       Date:  1996-07       Impact factor: 3.144

5.  In vitro maintenance of Leishmania amastigotes directly from lesions: advantages and limitations.

Authors:  V H Hodgkinson; L Soong
Journal:  J Parasitol       Date:  1997-10       Impact factor: 1.276

Review 6.  Nitric oxide and macrophage function.

Authors:  J MacMicking; Q W Xie; C Nathan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 7.  Molecular biology of nitric oxide synthases.

Authors:  D A Geller; T R Billiar
Journal:  Cancer Metastasis Rev       Date:  1998-03       Impact factor: 9.264

8.  Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.

Authors:  L Soong; S M Duboise; P Kima; D McMahon-Pratt
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Human and rodent interferon-gamma as a growth factor for Trypanosoma brucei.

Authors:  M Bakhiet; T Olsson; J Mhlanga; P Büscher; N Lycke; P H van der Meide; K Kristensson
Journal:  Eur J Immunol       Date:  1996-06       Impact factor: 5.532

10.  Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis.

Authors:  P E Kima; S L Constant; L Hannum; M Colmenares; K S Lee; A M Haberman; M J Shlomchik; D McMahon-Pratt
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

View more
  41 in total

1.  Differential microbicidal effects of human histone proteins H2A and H2B on Leishmania promastigotes and amastigotes.

Authors:  Yingwei Wang; Yang Chen; Lijun Xin; Stephen M Beverley; Eric D Carlsen; Vsevolod Popov; Kwang-Poo Chang; Ming Wang; Lynn Soong
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

2.  Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites.

Authors:  Lijun Xin; Diego A Vargas-Inchaustegui; Sharon S Raimer; Brent C Kelly; Jiping Hu; Leiyi Zhu; Jiaren Sun; Lynn Soong
Journal:  J Immunol       Date:  2010-05-12       Impact factor: 5.422

3.  IL-2 limits IL-12 enhanced lymphocyte proliferation during Leishmania amazonensis infection.

Authors:  Amanda E Ramer-Tait; Christine A Petersen; Douglas E Jones
Journal:  Cell Immunol       Date:  2011-04-09       Impact factor: 4.868

4.  Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200.

Authors:  Mauro Cortez; Chau Huynh; Maria Cecilia Fernandes; Kathleen A Kennedy; Alan Aderem; Norma W Andrews
Journal:  Cell Host Microbe       Date:  2011-06-16       Impact factor: 21.023

5.  Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection.

Authors:  René E Vasquez; Lijun Xin; Lynn Soong
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

6.  Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials.

Authors:  Anne Maurer-Cecchini; Saskia Decuypere; François Chappuis; Coralie Alexandrenne; Simonne De Doncker; Marleen Boelaert; Jean-Claude Dujardin; Louis Loutan; Jean-Michel Dayer; Gianfranco Tulliano; Jorge Arevalo; Alexandro Llanos-Cuentas; Carlo Chizzolini
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

7.  A deficiency in the B cell response of C57BL/6 mice correlates with loss of macrophage-mediated killing of Leishmania amazonensis.

Authors:  Katherine N Gibson-Corley; Paola M Boggiatto; Rami M Mukbel; Christine A Petersen; Douglas E Jones
Journal:  Int J Parasitol       Date:  2009-12-11       Impact factor: 3.981

8.  An improved method for detection of Leishmania amastigotes by an antibody probe against the small subunit of leishmanial ribonucleotide reductase.

Authors:  Shu-Ching Chang; Oleg Kuzmenok; Su-Chi Chiang; Sho Tone Lee
Journal:  Parasitol Res       Date:  2004-08-27       Impact factor: 2.289

9.  Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort Study.

Authors:  Aline C Muniz; Olívia Bacellar; Ednaldo Lima Lago; Augusto M Carvalho; Pedro Paulo Carneiro; Luiz Henrique Guimarães; Paulo N Rocha; Lucas P Carvalho; Marshall Glesby; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2016-05-18       Impact factor: 5.226

10.  CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing.

Authors:  Yannick F Vanloubbeeck; Amanda E Ramer; Fei Jie; Douglas E Jones
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.